Hai-Feng Pan
Anhui Medical University
409 Papers
1.4K Citations
Hai-Feng Pan is an academic researcher from Anhui Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 40, co-authored 356 publications.
Chat about Author
Papers
Potential roles of IL-9 in the pathogenesis of systemic lupus erythematosus.
Rui-Xue Leng,Hai-Feng Pan,Dong-Qing Ye,Yuekang Xu +3 more
- 23 Apr 2012
TL;DR: Recent advances on the role of IL-9 in the pathogenesis and treatment of SLE are summarized and implicated in the proliferation of several types of CD4+ T cells, indicating that IL- 9 may be therapeutically relevant in SLE.
Social Support and Depression Among Pulmonary Tuberculosis Patients in Anhui, China
Xue-Hui Fang,Qian Wu,Sha-Sha Tao,Zhi-Wei Xu,Yan-Feng Zou,Dongchun Ma,Hai-Feng Pan,Wenbiao Hu +7 more
TL;DR: The prevalence of depressive symptoms in pulmonary TB patients were high in Anhui Province, China and both education level and marital status were found to be correlated with social support and depression state, suggesting low levels of social support can be an important predictor of depression symptoms.
Emerging roles of air pollution and meteorological factors in autoimmune eye diseases.
TL;DR: In this article , the potential mechanisms underlying linkages of air pollution and meteorological factors to ocular autoimmune and inflammatory responses were discussed, and the specific roles of air pollutants and meteorology factors in several major AEDs including uveitis, Graves' ophthalmopathy (GO), ocular allergic disease (OAD), glaucoma, diabetic retinopathy (DR), etc.
Circular RNAs and systemic lupus erythematosus
TL;DR: It is appealing to speculate that circRNAs may associate with SLE and may be potential therapeutic targets for treatment of SLE, and to introduce reports exploring the association of circ RNAs with human diseases, and conjecture the potential roles ofcircRNAs in SLE.
Emerging role of semaphorin-3A in autoimmune diseases
TL;DR: Recent studies on the involvement of Sema3A in the pathogenesis of ADs are summarized and the discoveries obtained from recent findings may translate into novel therapeutic agent for ADs.